Rice Hall James & Associates’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.83M Sell
64,022
-5,472
-8% -$327K 0.21% 105
2025
Q1
$3.65M Sell
69,494
-384
-0.5% -$20.2K 0.21% 103
2024
Q4
$3.84M Sell
69,878
-1,721
-2% -$94.7K 0.21% 107
2024
Q3
$3.6M Sell
71,599
-439
-0.6% -$22.1K 0.19% 118
2024
Q2
$3.17M Sell
72,038
-4,673
-6% -$205K 0.19% 120
2024
Q1
$3.37M Sell
76,711
-166
-0.2% -$7.3K 0.19% 112
2023
Q4
$3.65M Sell
76,877
-629
-0.8% -$29.9K 0.21% 109
2023
Q3
$3.44M Buy
77,506
+12,960
+20% +$575K 0.22% 107
2023
Q2
$3.08M Sell
64,546
-7,725
-11% -$369K 0.17% 133
2023
Q1
$2.84M Sell
72,271
-967
-1% -$38.1K 0.16% 150
2022
Q4
$2.07M Sell
73,238
-2,968
-4% -$84K 0.12% 185
2022
Q3
$2.29M Buy
76,206
+162
+0.2% +$4.87K 0.13% 169
2022
Q2
$2.58M Sell
76,044
-5,072
-6% -$172K 0.12% 167
2022
Q1
$3.64M Sell
81,116
-48,814
-38% -$2.19M 0.14% 139
2021
Q4
$6M Buy
129,930
+9,531
+8% +$440K 0.21% 92
2021
Q3
$4.04M Sell
120,399
-91,926
-43% -$3.09M 0.15% 111
2021
Q2
$6.24M Sell
212,325
-18,000
-8% -$529K 0.22% 82
2021
Q1
$5.94M Buy
230,325
+1,531
+0.7% +$39.5K 0.19% 93
2020
Q4
$5.22M Buy
228,794
+7,287
+3% +$166K 0.18% 97
2020
Q3
$4.74M Buy
221,507
+72,898
+49% +$1.56M 0.19% 103
2020
Q2
$3.45M Buy
148,609
+79,689
+116% +$1.85M 0.15% 121
2020
Q1
$1.47M Buy
68,920
+12,109
+21% +$258K 0.08% 166
2019
Q4
$1.33M Buy
+56,811
New +$1.33M 0.04% 215